Pitt study may offer way to fight superbugs!

Professor Ron Montelaro directs a research project that focuses on the development of novel antibiotics that can be used to treat the ever increasing frequency of hospital and community infections caused by drug resistant bacteria. The recently published study demonstrates that the lead antibiotic peptides are able in a laboratory setting to inhibit diverse strains of multidrug resistant bacteria and to greatly reduce the propensity for bacteria to develop resistance as observed with standard antibiotics. The lead peptide antibiotics offer a new therapeutic regimen for the treatment of bacterial infections, especially those involving bacterial strains that are resistant to current antibiotics.

Read the full article from the Tribune Review here.